An easier way to be screened for Colorectal Cancer
InSure® ONE™ at-home- collection makes collection for colorectal cancer easier than ever. Your patients don’t have to handle stool and according to USMSTF annual FIT is more effective and less costly than stool DNA.1
Lung Cancer Mutation Panel
EGFR, KRAS and EML4-ALK Predict Eligibility for NSCLC Targeted Therapies. Help assess your patients with NSCLC being considered for treatment with an EGFR TKI.
Learn more about Quest Vantage hereditary cancer testing
Quest Vantage offers a portfolio of hereditary cancer tests with multiple test options for focused and comprehensive genetic testing and services. The insights provided by Quest Vantage can help patients and healthcare providers identify appropriate and proven strategies to help reduce these risks.
Rex DK, Boland CR, Dominitz JA, et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. multi-society task force on colorectal cancer. Am J Gastroenterol. 2017;112(7):1016-1030.